These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 1671560)
1. The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Hunger SP; Galili N; Carroll AJ; Crist WM; Link MP; Cleary ML Blood; 1991 Feb; 77(4):687-93. PubMed ID: 1671560 [TBL] [Abstract][Full Text] [Related]
2. New E2A/PBX1 fusion transcript in a patient with t(1;19)(q23;p13) acute lymphoblastic leukemia. Numata S; Kato K; Horibe K Leukemia; 1993 Sep; 7(9):1441-4. PubMed ID: 8103813 [TBL] [Abstract][Full Text] [Related]
3. Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia. Privitera E; Kamps MP; Hayashi Y; Inaba T; Shapiro LH; Raimondi SC; Behm F; Hendershot L; Carroll AJ; Baltimore D Blood; 1992 Apr; 79(7):1781-8. PubMed ID: 1348433 [TBL] [Abstract][Full Text] [Related]
4. Expression of identical E2A/PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia. Izraeli S; Henn T; Strobl H; Ludwig WD; Kovar H; Haas OA; Harbott J; Bartram CR; Gadner H; Lion T Leukemia; 1993 Dec; 7(12):2054-6. PubMed ID: 8255105 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies specific to the acute lymphoblastic leukemia t(1;19)-associated E2A/pbx1 chimeric protein: characterization and diagnostic utility. Sang BC; Shi L; Dias P; Liu L; Wei J; Wang ZX; Monell CR; Behm F; Gruenwald S Blood; 1997 Apr; 89(8):2909-14. PubMed ID: 9108411 [TBL] [Abstract][Full Text] [Related]
6. Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation. Lu Q; Wright DD; Kamps MP Mol Cell Biol; 1994 Jun; 14(6):3938-48. PubMed ID: 7910944 [TBL] [Abstract][Full Text] [Related]
7. [E2A gene in t(1;19)-ALL]. Hayashi Y Nihon Rinsho; 1992 Jun; 50(6):1369-73. PubMed ID: 1355570 [TBL] [Abstract][Full Text] [Related]
8. E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): a Pediatric Oncology Group study. Hunger SP; Fall MZ; Camitta BM; Carroll AJ; Link MP; Lauer SJ; Mahoney DH; Pullen DJ; Shuster JJ; Steuber CP; Cleary ML Blood; 1998 Feb; 91(3):1021-8. PubMed ID: 9446665 [TBL] [Abstract][Full Text] [Related]
9. Unexpected heterogeneity in E2A/PBX1 fusion messenger RNA detected by the polymerase chain reaction in pediatric patients with acute lymphoblastic leukemia. Izraeli S; Kovar H; Gadner H; Lion T Blood; 1992 Sep; 80(6):1413-7. PubMed ID: 1520867 [TBL] [Abstract][Full Text] [Related]
10. Molecular variants of the 1;19 chromosomal translocation in pediatric acute lymphoblastic leukemia (ALL). Privitera E; Luciano A; Ronchetti D; Aricò M; Santostasi T; Basso G; Biondi A Leukemia; 1994 Apr; 8(4):554-9. PubMed ID: 8152250 [TBL] [Abstract][Full Text] [Related]
12. Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia. Wiemels JL; Leonard BC; Wang Y; Segal MR; Hunger SP; Smith MT; Crouse V; Ma X; Buffler PA; Pine SR Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15101-6. PubMed ID: 12415113 [TBL] [Abstract][Full Text] [Related]
13. Hyperdiploidy and E2A-PBX1 fusion in an adult with t(1;19)+ acute lymphoblastic leukemia: case report and review of the literature. Hunger SP; Sun T; Boswell AF; Carroll AJ; McGavran L Genes Chromosomes Cancer; 1997 Dec; 20(4):392-8. PubMed ID: 9408756 [TBL] [Abstract][Full Text] [Related]
14. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. Kamps MP; Look AT; Baltimore D Genes Dev; 1991 Mar; 5(3):358-68. PubMed ID: 1672117 [TBL] [Abstract][Full Text] [Related]
15. Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses. Izraeli S; Janssen JW; Haas OA; Harbott J; Brok-Simoni F; Walther JU; Kovar H; Henn T; Ludwig WD; Reiter A Leukemia; 1993 May; 7(5):671-8. PubMed ID: 8483319 [TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of the t(1;19)(q23;p13) translocation observed in adult leukemias. Mitani K; Sasaki K; Ogawa S; Hayashi Y; Mano H; Yazaki Y; Hirai H Int J Hematol; 1994 Dec; 60(4):267-71. PubMed ID: 7894030 [TBL] [Abstract][Full Text] [Related]
17. Establishment of a novel cell line (TS-2) of pre-B acute lymphoblastic leukemia with a t(1;19) not involving the E2A gene. Yoshinari M; Imaizumi M; Eguchi M; Ogasawara M; Saito T; Suzuki H; Koizumi Y; Cui Y; Sato A; Saisho T; Ichinohasama R; Matsubara Y; Kamada N; Iinuma K Cancer Genet Cytogenet; 1998 Mar; 101(2):95-102. PubMed ID: 9494609 [TBL] [Abstract][Full Text] [Related]
19. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line. Casagrande G; te Kronnie G; Basso G Haematologica; 2006 Jun; 91(6):765-71. PubMed ID: 16769578 [TBL] [Abstract][Full Text] [Related]
20. Expression of the E2A-PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemia with different B lineage immunophenotypes. Devaraj PE; Foroni L; Janossy G; Hoffbrand AV; Secker-Walker LM Leukemia; 1995 May; 9(5):821-5. PubMed ID: 7769844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]